Dec 11, 2025 07:47AM
Nov 6, 2025 04:02PM
Sep 10, 2025 07:47AM
Sep 10, 2025 07:47AM
Aug 7, 2025 04:06PM
May 29, 2025 08:00AM
May 13, 2025 04:06PM Intensity Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
Mar 13, 2025 04:07PM
Jan 28, 2025 08:03AM
Jan 28, 2025 08:00AM
Jan 10, 2025 08:00AM
Nov 18, 2024 08:00AM
Nov 18, 2024 08:00AM
May 10, 2024 08:03AM Intensity Therapeutics (INTS) and The Swiss Group for Clinical Cancer Research SAKK Sign a Collaboration Agreement to Conduct a Phase 2 Randomized, Clinical Trial in Early-Stage Breast Cancer in Europ
May 10, 2024 08:01AM
Mar 14, 2024 04:09PM
Jan 3, 2024 08:05AM
Jan 3, 2024 08:01AM
Sep 7, 2023 08:02AM
Sep 7, 2023 08:01AM
Jun 6, 2023 07:35AM Intensity Therapeutics Reports INT230-6 Can Cause Immune Priming in Historically Quiescent Breast Cancers
Jun 3, 2023 08:00AM
Nov 10, 2022 07:01AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All